Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$331K Sell
2,751
-8,488
-76% -$980K 0.68% 9
2025
Q4
$1.18M Hold
11,239
1.02% 15
2025
Q3
$943K Buy
11,239
+68
+0.6% +$5.6K 0.8% 32
2025
Q2
$884K Sell
11,171
-13,475
-55% -$1.07M 0.74% 38
2025
Q1
$2.21M Buy
24,646
+10,923
+80% +$1.02M 1.04% 37
2024
Q4
$1.37M Buy
13,723
+1,061
+8% +$109K 0.63% 45
2024
Q3
$1.44M Buy
12,662
+508
+4% +$60.4K 0.95% 46
2024
Q2
$1.5M Buy
12,154
+154
+1% +$19.8K 1.05% 34
2024
Q1
$1.58M Hold
12,000
1.15% 31
2023
Q4
$1.32M Buy
+12,000
New +$1.25M 1.09% 41

Other funds holding MRK

OV Management's MRK Position: Q1 2026 in Review

OV Management reduced its Merck (MRK) stake by 76% in Q1 2026, selling an estimated $980K and leaving 2,751 shares worth $331K. The position accounts for 0.68% of the portfolio, ranked #9.

OV Management first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.21M in Q1 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • OV Management held 2,751 shares of Merck worth $331K as of Q1 2026.
  • OV Management sold 8,488 Merck shares in Q1 2026, an estimated $980K.
  • Merck made up 0.68% of OV Management's portfolio in Q1 2026, its #9 holding.
  • OV Management first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • OV Management's Merck position peaked at $2.21M in Q1 2025.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on OV Management's 13F filing for Q1 2026, filed 14 Apr 2026.